Eric C Hsu
CIK 1817867 · View on SEC EDGAR ↗
Insider
First SEC filing: Nov. 12, 2020 · Latest: Nov. 12, 2020
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net:
$0
+ 14 non-open-market transactions below
last 12 months, based on the transactions shown below
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Dec. 19, 2025 | INM | A | 13,000 | — | — | 18,280 Direct | +246.21% | Acquired | (price as of 2026-08-19) |
| Dec. 15, 2025 | INM | H | 70 | — | — | 5,280 Direct | -1.31% | Disposed | (price as of 2026-08-19) |
| Dec. 20, 2024 | INM | A | 2,750 | — | — | 5,350 Direct | +105.77% | Acquired | (price as of 2026-08-19) |
| May 27, 2024 | INM | H | 545 | — | — | 52,000 Direct | -1.04% | Disposed | (price as of 2026-08-19) |
| March 4, 2024 | INM | H | 309 | — | — | 52,545 Direct | -0.58% | Disposed | (price as of 2026-08-19) |
| Dec. 23, 2023 | INM | A | 45,000 | — | — | 52,854 Direct | +572.96% | Acquired | (price as of 2026-08-19) |
| Aug. 31, 2023 | INM | H | 327 | — | — | 7,854 Direct | -4.00% | Disposed | (price as of 2026-08-19) |
| May 16, 2023 | INM | H | 152 | — | — | 8,181 Direct | -1.82% | Disposed | (price as of 2026-08-19) |
| March 8, 2023 | INM | H | 545 | — | — | 8,333 Direct | -6.14% | Disposed | (price as of 2026-08-19) |
| Dec. 16, 2022 | INM | A | 4,200 | — | — | 8,878 Direct | +89.78% | Acquired | (price as of 2026-08-19) |
| Nov. 14, 2022 | INM | D | 4,200 | — | — | 4,678 Direct | -47.31% | Disposed | (price as of 2026-08-19) |
| Nov. 14, 2022 | INM | A | 4,200 | — | — | 8,878 Direct | +89.78% | Acquired | (price as of 2026-08-19) |
| Oct. 18, 2021 | INM | A | 35,000 | — | — | 116,969 Direct | +42.70% | Acquired | (price as of 2026-08-19) |
| Dec. 16, 2020 | INM | A | 35,000 | — | — | 35,000 Direct | — | Acquired | (price as of 2026-08-19) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Dec. 19, 2025 | INM | Employee Stock Option (Right to Buy) | Common shares (13,000) | $1.29 | Dec. 18, 2030 | 13,000 | Acquired |
| Dec. 15, 2025 | INM | Employee Stock Option (Expiration) | Common shares (70) | — | Dec. 15, 2025 | 70 | Disposed |
| Dec. 20, 2024 | INM | Employee Stock Option (Right to Buy) | Common shares (2,750) | $4.14 | Dec. 19, 2029 | 2,750 | Acquired |
| May 27, 2024 | INM | Employee Stock Option (Expiration) | Common shares (545) | — | May 27, 2024 | 545 | Disposed |
| March 4, 2024 | INM | Employee Stock Option (Expiration) | Common shares (309) | — | March 4, 2024 | 309 | Disposed |
| Dec. 23, 2023 | INM | Employee Stock Option (Right to Buy) | Common shares (45,000) | $0.37 | Dec. 22, 2028 | 45,000 | Acquired |
| Aug. 31, 2023 | INM | Employee Stock Option (Expiration) | Common shares (327) | — | Aug. 31, 2023 | 327 | Disposed |
| May 16, 2023 | INM | Employee Stock Option (Expiration) | Common shares (152) | — | May 16, 2023 | 152 | Disposed |
| March 8, 2023 | INM | Employee Stock Option (Expiration) | Common shares (545) | — | March 8, 2023 | 545 | Disposed |
| Dec. 16, 2022 | INM | Employee Stock Option (Right to Buy) | Common shares (4,200) | $1.78 | Dec. 15, 2027 | 4,200 | Acquired |
| Nov. 14, 2022 | INM | Employee Stock Option (Right to Buy) | Common shares (4,200) | $2.78 | Nov. 13, 2027 | 4,200 | Disposed |
| Nov. 14, 2022 | INM | Employee Stock Option (Right to Buy) | Common shares (4,200) | $2.78 | Nov. 13, 2027 | 4,200 | Acquired |
| Oct. 18, 2021 | INM | Employee Stock Option (Right to Buy) | Common shares (35,000) | $1.40 | Oct. 17, 2026 | 35,000 | Acquired |
| Dec. 16, 2020 | INM | Employee Stock Option (Right to Buy) | Common shares (35,000) | — | Dec. 15, 2025 | 35,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 6 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Nov. 12, 2020 | INM | Common Shares | 1,273 | Direct |
| Nov. 12, 2020 | INM | Employee Stock Option (Right to Buy)→ Common Shares (3,788) | 3,788 | Direct |
| Nov. 12, 2020 | INM | Employee Stock Option (Right to Buy)→ Common Shares (8,182) | 8,182 | Direct |
| Nov. 12, 2020 | INM | Employee Stock Option (Right to Buy)→ Common Shares (7,727) | 7,727 | Direct |
| Nov. 12, 2020 | INM | Employee Stock Option (Right to Buy)→ Common Shares (13,636) | 13,636 | Direct |
| Nov. 12, 2020 | INM | Employee Stock Option (Right to Buy)→ Common Shares (13,636) | 13,636 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
INM
President, Preclinical Research & Development| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2025 | $267,942,261,000,216,992 | $469,494,570,038,000 | — | — | — | — | — | $323,623,322,500,260,480 |
| 2024 | $261,000 | $45,700 | — | — | — | — | — | $322,500 |
| 2022 | $253,461 | — | — | — | — | — | — | $282,917 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.